Logo-ipp

Immunopathol Persa. 2025;In Progress; 11(2): e41698. doi: 10.34172/ipp.2024.41698

Original

Evaluation of Philadelphia-negative myeloproliferative neoplasms in Erbil Iraq; analysis of JAK 2, CALR, and MPL mutations

Mohammed Jarjees Hashm * ORCID, Isik Didem Karagoz * ORCID

Cited by CrossRef: